BioSpace News Archive

Acquisition aims to maximize synergy through combined technologies

EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2) (the “Company” or “EXM”), a producer of refined cannabis ingredients for the pharmaceutical, medical, nutraceutical, and cosmetic industries, provides an update on our operations, the first closing of a loan agreement and the measures we have taken in response to the current COVID-19 global pandemic.

Astaxanthin from Haematococcus pluvialis microalgae has demonstrated wide-ranging effects on immune system modulation as evidenced in 28 pre-clinical as well as five human clinical trials.

Titan Medical Inc. announce today that it has entered into definitive agreements with institutional investors that provide for the purchase and sale of 7,000,000 common shares of the Comp

RedHill Biopharma Ltd., a specialty biopharmaceutical company focused on gastrointestinal diseases, provided a business update on proactive measures being taken with regard to the COVID-19 virus outbreak.

ADVANZ PHARMA Corp. Limited, an international specialty pharmaceutical company focused on serving the needs of patients and healthcare providers around the world with enhanced access to high quality, niche-established medicines, announced its financial and operational results for the three and twelve months ended December 31, 2019.

Conference call and webcast at 10:00AM EST to discuss MDNA19 results with pre-clinical experts showing robust immune responses without toxicity

IMV Inc., a clinical-stage biopharmaceutical company pioneering a novel class of immunotherapies, announced that it will hold a conference call and webcast on Wednesday, March 31, 2020 at 8:00 a.m.

4BIO Capital and Arkin Bio Ventures lead first close joined by Takeda Ventures and existing investors

New lab results from BLUEWAVE Technologies, Inc. indicate that when used as directed, its BLUEWAVE device can effectively kill the non-enveloped virus, MS2 Bacteriophage, and Methicillin Resistant Staphylococcus Aureus..